
* Department of Microbiology, University of Tennessee, Knoxville; and
Department of Immunology, Cleveland Clinic Foundation, Ohio
Correspondence: Dr. Barry T. Rouse, Department of Microbiology, M409 Walters Life Sciences Building, University of Tennessee, Knoxville, TN 37996-0845. E-mail: btr{at}utk.edu
Topical application of plasmid DNA encoding IL-12 to the cornea of mice
prior to ocular infection with Herpes simplex virus type 1 (HSV)
results in diminished corneal immunoinflammatory lesions. Such herpetic
stromal keratitis (HSK) reactions in humans represent an important
cause of blindness. The effect of IL-12 pretreatment acted via
inhibitory effects on corneal neovascularization rather than by
inhibiting viral replication or the function of CD4+ T
cells that mediate HSK. The antiangiogenesis induced by IL-12 DNA
application was mediated indirectly via the cytokine IFN-
and one or
both of two chemokine molecules, IP-10 and MIG. Thus IL-12 DNA
administration lacked modulatory effects on HSK in GKO mice, indicating
the necessary involvement of IFN-
induction for antiangiogenesis. In
contrast, exposure of GKO mice to IP-10 DNA did suppress the severity
of HSK. Furthermore, treatment with specific antisera to IP-10 and MIG
in HSV-infected mice abrogated the IL-12-induced inhibitory effect on
lesion severity. Taken together, our data indicate that the HSV-induced
ocular immunoinflammatory lesions can be modulated by IL-12 and that
this effect results from chemokine inhibition of angiogenesis. The use
of antiangiogenesis therapy might represent a useful control measure
against HSK.
Key Words: herpetic stromal keratitis chemokine cytokine immunopathology
This article has been cited by other articles:
![]() |
I. Bettahi, A. B. Nesburn, S. Yoon, X. Zhang, A. Mohebbi, V. Sue, A. Vanderberg, S. L. Wechsler, and L. BenMohamed Protective Immunity against Ocular Herpes Infection and Disease Induced by Highly Immunogenic Self-Adjuvanting Glycoprotein D Lipopeptide Vaccines Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4643 - 4653. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kim, S. Suvas, P. P. Sarangi, S. Lee, R. A. Reisfeld, and B. T. Rouse Vascular Endothelial Growth Factor Receptor 2-Based DNA Immunization Delays Development of Herpetic Stromal Keratitis by Antiangiogenic Effects J. Immunol., September 15, 2006; 177(6): 4122 - 4131. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kim, S. Lee, S. Suvas, and B. T. Rouse Application of Plasmid DNA Encoding IL-18 Diminishes Development of Herpetic Stromal Keratitis by Antiangiogenic Effects J. Immunol., July 1, 2005; 175(1): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Bermudez-Humaran, P. Langella, N. G. Cortes-Perez, A. Gruss, R. S. Tamez-Guerra, S. C. Oliveira, O. S. Cardenas, R. Montes de Oca-Luna, and Y. Le Loir Intranasal Immunization with Recombinant Lactococcus lactis Secreting Murine Interleukin-12 Enhances Antigen-Specific Th1 Cytokine Production Infect. Immun., April 1, 2003; 71(4): 1887 - 1896. [Abstract] [Full Text] |
||||